Sun Phar­ma, Taro Phar­ma­ceu­ti­cal reach $75M set­tle­ment agree­ment in al­leged price fix­ing scheme

The In­di­an multi­na­tion­al drug­mak­er Sun Phar­ma, along­side Is­rael’s Taro Phar­ma­ceu­ti­cal In­dus­tries, is cash­ing out tens of mil­lions to set­tle a law­suit in a US fed­er­al court.

In a mo­tion dat­ed Thurs­day, fed­er­al judge Cyn­thia M. Rufe out of Penn­syl­va­nia’s east­ern dis­trict signed off on a set­tle­ment that would re­solve an­titrust lit­i­ga­tion in­volv­ing Sun Phar­ma and Taro Phar­ma­ceu­ti­cals. The eight-page or­der de­tailed that the val­ue was set for $75 mil­lion, with the chance for an­oth­er $20 mil­lion to be added based on spe­cif­ic claus­es in the set­tle­ment agree­ment.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER